State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.
Nanoform Finland Plc announced plans to explore the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery.